Lebwohl M - Search Results

1

Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome.

Rapaport MJ, Lebwohl M. Rapaport MJ, et al. Among authors: lebwohl m. Clin Dermatol. 2003 May-Jun;21(3):201-14. doi: 10.1016/s0738-081x(02)00365-6. Clin Dermatol. 2003. PMID: 12781438 No abstract available.

2

Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.

Gordon ML, Lebwohl MG, Phelps RG, Cohen SR, Fleischmajer R. Gordon ML, et al. Among authors: lebwohl mg. Arch Dermatol. 1991 Feb;127(2):217-20. Arch Dermatol. 1991. PMID: 1990986

3

Cutaneous reactions to vitamin K1 injections.

Lemlich G, Green M, Phelps R, Lebwohl M, Don P, Gordon M. Lemlich G, et al. Among authors: lebwohl m. J Am Acad Dermatol. 1993 Feb;28(2 Pt 2):345-7. doi: 10.1016/0190-9622(93)70051-t. J Am Acad Dermatol. 1993. PMID: 8436655

4

Recalcitrant pyoderma gangrenosum: treatment with thalidomide.

Hecker MS, Lebwohl MG. Hecker MS, et al. Among authors: lebwohl mg. J Am Acad Dermatol. 1998 Mar;38(3):490-1. doi: 10.1016/s0190-9622(98)70513-4. J Am Acad Dermatol. 1998. PMID: 9520035 No abstract available.

5

Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.

Lebwohl MG, Tan MH, Meador SL, Singer G. Lebwohl MG, et al. J Am Acad Dermatol. 2001 Jan;44(1):77-82. doi: 10.1067/mjd.2001.110046. J Am Acad Dermatol. 2001. PMID: 11148481 Clinical Trial.

6

Cost of atopic dermatitis and eczema in the United States.

Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Ellis CN, et al. Among authors: lebwohl m. J Am Acad Dermatol. 2002 Mar;46(3):361-70. doi: 10.1067/mjd.2002.120528. J Am Acad Dermatol. 2002. PMID: 11862170

7

Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.

Endzweig-Gribetz CH, Brady C, Lynde C, Sibbald D, Lebwohl M. Endzweig-Gribetz CH, et al. Among authors: lebwohl m. J Cutan Med Surg. 2002 May-Jun;6(3 Suppl):12-6. doi: 10.1177/12034754020060S304. Epub 2002 Apr 30. J Cutan Med Surg. 2002. PMID: 11976987 Review. No abstract available.

8

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. Lebwohl M, et al. Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x. Int J Dermatol. 2002. PMID: 12100701 Clinical Trial.

9

An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas.

Tan MH, Meador SL, Singer G, Lebwohl MG. Tan MH, et al. Int J Dermatol. 2002 Nov;41(11):804-9. doi: 10.1046/j.1365-4362.2002.01571.x. Int J Dermatol. 2002. PMID: 12453011

10

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.

Galadari H, Fuchs B, Lebwohl M. Galadari H, et al. Among authors: lebwohl m. Int J Dermatol. 2003 Mar;42(3):231-7. doi: 10.1046/j.1365-4362.2003.01449.x. Int J Dermatol. 2003. PMID: 12653923 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results